PEAK6’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.07M Sell
13,100
-21,000
-62% -$7.79M 0.01% 846
2026
Q1
$9.98M Sell
34,100
-25,700
-43% -$8.45M 0.02% 579
2025
Q4
$21M Buy
59,800
+15,800
+36% +$5.34M 0.04% 367
2025
Q3
$14.2M Buy
44,000
+33,800
+331% +$10.5M 0.02% 540
2025
Q2
$3.97M Sell
10,200
-4,000
-28% -$1.61M 0.01% 1077
2025
Q1
$6.18M Sell
14,200
-4,700
-25% -$1.89M 0.01% 805
2024
Q4
$6.97M Buy
+18,900
New +$7.91M 0.01% 723

Other funds holding ELV

PEAK6's ELV Position: Q2 2026 in Review

PEAK6 opened a new position in Elevance Health (ELV) in Q2 2026: 888 shares worth $343K. The stake represents ﹤0.01% of the portfolio and ranks #2106 among its holdings. This is a return to the name: PEAK6 previously reported a position in ELV as recently as Q4 2025.

PEAK6 first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.8M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • PEAK6 held 888 shares of Elevance Health worth $343K as of Q2 2026.
  • Elevance Health was a new PEAK6 position in Q2 2026.
  • Elevance Health made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2106 holding.
  • PEAK6 first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • PEAK6's Elevance Health position peaked at $10.8M in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.